Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -4.92%. However, over the past six months, we’ve seen a stronger performance of -19.56%. The price of DYN fallen by 47.72% over the last 30 days. And in the last five days, it has surged by 26.67%.
The stock price for Dyne Therapeutics Inc (DYN) currently stands at $11.02. The stock experienced a substantial increase in the last session, hitting $11.03 after starting at $9.85. The stock’s lowest price was $9.82 before closing at $9.77.
In terms of market performance, Dyne Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $15.60 on 03/06/23, and the lowest value was recorded at $6.40 on 10/30/23.
52-week price history of DYN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dyne Therapeutics Inc’s current trading price is -29.36% away from its 52-week high, while its distance from the 52-week low is 72.19%. The stock’s price range during this period has varied between$6.40 and $15.60. The Dyne Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.59 million for the day, a figure considerably higher than their average daily volume of 0.54 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dyne Therapeutics Inc (DYN) has experienced a quarterly rise of 1.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 676.41M and boasts a workforce of 123 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.90, with a change in price of +0.38. Similarly, Dyne Therapeutics Inc recorded 484,193 in trading volume during the last 100 days, posting a change of +3.57%.
DYN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DYN stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.15.
DYN Stock Stochastic Average
Dyne Therapeutics Inc’s raw stochastic average for the past 50 days is presently 91.39%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 95.36%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 85.76% and 86.94%, respectively.